AMY SCHMETZER: Open Payments
NPI 1083178826 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 22 payments from 7 companies in 2025. Trend: 2023 $4,592 · 2024 $2,932 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $610 |
| GlaxoSmithKline, LLC. | 4 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Electromed, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
Products named: FASENRA, NUCALA, AIRSUPRA, TEZSPIRE, DUPIXENT, OFEV, SMARTVEST, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
